Literature DB >> 4970947

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.

B Fisher, R G Ravdin, R K Ausman, N H Slack, G E Moore, R J Noer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4970947      PMCID： PMC1387335          DOI： 10.1097/00000658-196809000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  ADJUVANT CHEMOTHERAPY. THIO-TEPA WITH RADICAL MASTECTOMY IN THE TREATMENT OF BREAST CANCER.

Authors:  R J NOER
Journal:  Am J Surg       Date:  1963-09       Impact factor: 2.565

2.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

3.  The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats.

Authors:  G O MCDONALD; E P CRUZ; W H COLE
Journal:  Surg Forum       Date:  1957

4.  The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma.

Authors:  E R FISHER; R B TURNBULL
Journal:  Surg Gynecol Obstet       Date:  1955-01

5.  Is there an increased risk?

Authors:  I D BROSS
Journal:  Fed Proc       Date:  1954-09

6.  Breast Adjuvant Chemotherapy: Effectiveness of Thio-Tepa (Triethylenethiophosphoramide) as Adjuvant to Radical Mastectomy for Breast Cancer.

Authors: 
Journal:  Ann Surg       Date:  1961-10       Impact factor: 12.969

7.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1894-11       Impact factor: 12.969

8.  A commentary. Selected considerations regarding chemotherapy as adjuvant in cancer treatment.

Authors:  E Frei
Journal:  Cancer Chemother Rep       Date:  1966 Jan-Feb

9.  The prophylactic treatment of malignant disease with nitrogen mustard and triethylenethiophosphoramide (thio-TEPA).

Authors:  G O MCDONALD; C LIVINGSTON; C F BOYLES; W H COLE
Journal:  Ann Surg       Date:  1957-05       Impact factor: 12.969

10.  Prophylactic treatment of cancer; the use of chemotherapeutic agents to prevent tumor metastasis.

Authors:  E P CRUZ; G O MCDONALD; W H COLE
Journal:  Surgery       Date:  1956-08       Impact factor: 3.982
View more
  59 in total

1.  Credentialing for breast lymphatic mapping: how many cases are enough?

Authors:  H S Cody; A D Hill; K N Tran; M F Brennan; P I Borgen
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.

Authors:  M Noguchi; T Taniya; N Koyasaki; N Ohta; I Miyazaki
Journal:  Jpn J Surg       Date:  1991-11

4.  Endocrine adjuvant therapy in breast cancer.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1976-10-30

5.  Advances in the treatment of carcinoma of the breast.

Authors:  L H Smith; M Bozdech
Journal:  West J Med       Date:  1976-11

6.  The role of skeletal scintigraphy in detection of metastatic breast cancer.

Authors:  C S Galasko
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

7.  Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression.

Authors:  S R Grey; S S Dlay; B E Leone; F Cajone; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Cancer of the breast: Its outcome as measured by the rate of dying and causes of death.

Authors:  C B Mueller; W Jeffries
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

9.  Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro?

Authors:  A Tabuenca; S Mohan; C A Garberoglio; P I Borgen; T Rosol; T A Linkhart
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

10.  [Intra- or Postoperative Chemoprophylaxis? (author's transl)].

Authors:  H J Senn
Journal:  Langenbecks Arch Chir       Date:  1975-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.